Baker Tilly Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Baker Tilly Wealth Management's IDXX Position: Q2 2026 in Review
Baker Tilly Wealth Management reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, selling an estimated $48.8K and leaving 591 shares worth $311K. The position accounts for 0.07% of the portfolio, ranked #216.
Baker Tilly Wealth Management first reported a position in IDXX in Q1 2021 and has held it in 18 quarters since. The position peaked at $838K in Q1 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Baker Tilly Wealth Management held 591 shares of Idexx Laboratories worth $311K as of Q2 2026.
- Baker Tilly Wealth Management sold 87 Idexx Laboratories shares in Q2 2026, an estimated $48.8K.
- Idexx Laboratories made up 0.07% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #216 holding.
- Baker Tilly Wealth Management first reported a position in Idexx Laboratories in Q1 2021 and has held it in 18 quarters since.
- Baker Tilly Wealth Management's Idexx Laboratories position peaked at $838K in Q1 2023.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.